Regencell Bioscience Holdings (RGC) Debt Ratio (2020)
Regencell Bioscience Holdings' (RGC) quarterly Debt Ratio came in at 5.97 in Q2 2020.
Regencell Bioscience Holdings (RGC) Debt Ratio (2020) Analysis & Trends
Regencell Bioscience Holdings (RGC) has 1 years of Debt Ratio data on file, last reported at 5.97 in Q2 2020.
- Quarterly Debt Ratio changed N/A year-over-year to 5.97 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was 5.97 (changed N/A YoY) and the FY2020 annual result came in at 5.97, changed N/A from the prior year.
- Debt Ratio steadied at 5.97 in Q2 2020.
- In the past five years, Debt Ratio ranged from a high of 5.97 in Q2 2020 to a low of 5.97 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 0.12 |
| 10 | Regencell Bioscience Holdings | 2.69 Bn | 2.69 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 5.97 |